LGP — Little Green Pharma Cashflow Statement
0.000.00%
- AU$30.33m
- AU$32.63m
- AU$36.82m
- 37
- 92
- 44
- 61
Annual cashflow statement for Little Green Pharma, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 9 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 24.6 | -18.3 | -9.21 | -8.15 | -4.79 |
Depreciation | |||||
Non-Cash Items | -23.6 | 1.01 | 1.29 | 3.44 | 3.98 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -6.81 | -0.895 | -2.01 | 1.7 | -3.83 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -5.15 | -17.2 | -6.94 | 0.067 | -0.917 |
Capital Expenditures | -11.6 | -7.66 | -4.93 | -1.44 | -0.726 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1.1 | — | -9.1 | -1.36 | -0.409 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -12.7 | -7.66 | -14 | -2.8 | -1.14 |
Financing Cash Flow Items | -2.24 | — | -0.838 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 53.9 | 4.73 | 13 | -4.72 | -0.53 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 36 | -20.2 | -7.69 | -7.43 | -2.6 |